Genetic Signatures of Differentiation Induced by 1α ,25-Dihydroxyvitamin D3 in Human Colon Cancer Cells

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7799-7806

  Pálmer, Héctor G ^a   Sánchez Carbayo, Marta ^b   Ordóñez Morán, Paloma ^a   Larriba, María Jesús ^a   Cordón Cardó, Carlos ^b   Muñoz, Alberto ^a,c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; COLON CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; DNA SYNTHESIS; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRACELLULAR SPACE; NORTHERN BLOTTING; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; ANTICARCINOGENIC AGENTS; CALCITRIOL; CELL LINE, TUMOR; COLONIC NEOPLASMS; DACTINOMYCIN; DRUG INTERACTIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 18544397070     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Holick, M. F. Sunlight and vitamin D: the bone and cancer connections. Radiation Protection Dosimetry, 91: 65-71, 2000.
2. 3 and its analogs on growth control and tumorigenesis. Front. Biosci., 6: D820-D848, 2001.
3. Díaz, G. D., Paraskeva, C., Thomas, M. G., Binderup, L., and Hague, A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implication for prevention and therapy. Cancer Res., 60: 2304-2312, 2000.
4. Park, W. H., Seol, J. G., Kim, E. S., Jung, C. W., Lee, C. C., Binderup, L., Koeffler, H. P., Kim, B. K., and Lee., Y. Y. Cell cycle arrest induced by the vitamin D (3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp. Cell Res., 254: 279-286, 2000.
5. Colston, K. W., and Hansen, C. M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer, 9: 45-59, 2002.
6. Majewski, S., Szmurlo, A., Marczak, M., Jablonska, S., and Bollag, W. Inhibition of tumor cell-induced angiogenesis by retinoids, 1α, 25-ditiydroxyvitamin D3 and their combination. Cancer Lett., 75: 35-39, 1993.
7. Koli, K., and Keski-Oja, J. 1α,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ., 11: 221-229, 2000.
8. Evans, S. R., Shchepotin, E. I., Young, H., Rochon, J., Uskokovic, M., and Shchepotin, I. B. 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1, 2-dimethylhydrazine-induced colon carcinogenesis model. Int. J. Oncol., 16: 1249-1254, 2000.
9. Akhter, J., Chen, X., Bowrey, P., Bolton, E. J., and Morris, D. L. Vitamin D3 analog, EB 1089, inhibits growth of subcutaneous xenographs of the human colon cancer cell line, LoVo, in nude mouse model. Dis. Colon Rectum, 40: 317-321, 1997.
10. van Weelden, K., Flanagan, L., Binderup, L. Tenniswood, M., and Welsh, J. Apoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089. Endocrinology, 139: 2102-2110, 1998.
11. Metha, R. G., and Metha, R. R. Vitamin D and cancer. J. Nutr. Biochem., 13: 252-264, 2002.
12. Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., Quintanilla, M., Cano, A., García de Herreros, A., Lafarga, M., and Muñoz, A. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J. Cell Biol., 154: 369-388, 2001.
13. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA - Cancer J. Clin., 47: 5-27, 1997.
14. Garland, C. F., Garland, F. C., Shaw, E. K., Comstock, G. W., Helsing, K. J., and Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2: 1176-1178, 1989.
15. Newmark, H. L., and Lipkin, M. Calcium, vitamin D, and colon cancer. Cancer Res., 52: 2067-2070, 1992.
16. Gulliford, T., English, J., Colston, K. W., Menday, P., Moller, S., and Coombes, R. C. A Phase 1 study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br. J. Cancer, 78: 6-13, 1998.
17. Gross, C., Stamey, T., Hancock, S., and Feldman, D. Treatment of early recurrent prostate cancer with 1, 25-dihydroxyvitamin D3 (calcitriol). J. Urol., 160, 2035-2040, 1998.
18. Smith, D. C., Johnson, C. S., Freeman, C. C., Muindi, J., Wilson, J. W., and Trump, D. L. A phase I trial of calcitriol (1α, 25-dihydroxycholecalciferol) in patients with advanced malignancy. Clin. Cancer Res., 5: 1339-1345, 1999.
19. Jurutka, P. W., Whitfield, G. K., Hsieh, J-C., Thompson, P. D., Haussler, C. A., and Haussler, M. R. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev. Endocr. Metab. Disord., 2: 203-216, 2001.
20. McDonald, P. N., Kraichely, D. M., and Brown, A. J. The vitamin D receptor. In T. P. Burris and E. R. B. McCabe (eds.), Nuclear Receptors and Genetic Disease, pp. 197-243. London, UK: Academic Press, Inc., 2001.
21. Ingles, S. A., Wang, J., Coetzee, G. A., Lee, E. R., Frankl, H. D., and Haile, R. W. Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control, 12: 607-614, 2001.
22. Ikuyama, T., Hamasaki, T., Inatomi, H., Katoh, T., Muratani, T., and Matsumoto, T. Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese. Endocrinol. J., 49: 433-438, 2002.
23. Vandewalle, B., Adenis, A., Homez, L., Revillion, F., and Lefebvre. J. 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett., 86: 67-73, 1994.
24. Tomita, N., Jiang, W., Hibshoosh, H., Warburton, D., Kahn, S. M., and Weinstein, I. B. Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell lines. Cancer Res., 52: 6840-6847, 1992.
25. Hewitt, R. E., McMarlin, A., Kleiner, D., Werso, R., Martin, P., Tsokas, M., Stamp, G. W. H., and Stetler-Stevenson, W. G. Validation of a model of colon cancer progression. J. Pathol., 192: 446-454, 2000.
26. Eisen, M. B., Spellman, P. T., Brown, P. O., and Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA, 95: 14863-4868, 1998.
27. Felsenstein, J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution, 39: 783-791, 1985.
28. Vennström, B., and Bishop, J. M. Isolation and characterization of chicken DNA homologous to the two putative oncogenes of avian erythroblastosis virus. Cell, 28: 135-143, 1982.
29. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
30. Church, G. M., and Gilbert, W. Genome sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
31. Freedman, L. P. Transcriptional targets of the vitamin D3 receptor-mediating cell cycle arrest and differentiation. J. Nutr., 129: 581S-586S 1999.
32. 3 and its analog EB1089 under growth inhibitory conditions in squamous carcinoma cells. Mol. Endocrinol., 15: 1127-1139, 2001.
33. 3 analog EB 1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol., 16: 1243-1256, 2002.
34. Mahoney, M. G., Simpson, A., Jost, M., Noe, M., Kapi, C., Pepe, D., Choi, Y. W., Uitto, J., and Rodeck, U. Metastasis-associated protein (MTA) 1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene, 21: 2161-2170, 2002.
35. Lorain, S., Quivy, J-P., Monier-Gavelle, F., Scamps, C., Lécluse, Y., Almouzni, G., and Lipinski, M. Core histones and HIRIP3, a novel histone-binding protein, directly interact with WD repeat protein HIRA. Mol. Cell. Biol., 18: 5546-5556, 1998.
36. Yuan, Y., Méndez, R., Sahin, R., and Dai, D. L. Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res., 61: 5558-5561, 2001.
37. Dhar, S., Bahgava, R., Yunes, M., Li, B., Goyal, J., Naber, S. P., Wazer, D. E., and Band, V. Analysis of normal epithelial cell specific-1 (NES1)/kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer. Clin. Cancer Res., 7: 3393-3398, 2001.
38. Goyal, J., Smith, K. M., Cowan, J. M., Wazer, D. E., Lee, S. W., and Band, V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res., 58: 4782-4786, 1988.
39. Bharaj, B. B., Luo, L. Y., Jung, K., Stephan, C., and Diamandis, E. P. Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers. Prostate, 51: 35-41, 2002.
40. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kawabata, M., Miyazono, K., and Kato, S. Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science (Wash. DC), 283: 1317-1321, 1999.
41. Kadakia, M., Brown, T. L., McGorry, M. M., and Berberich, S. J. MdmX inhibits Smad transactivation. Oncogene, 21: 8776-8785, 2002.
42. Haglund, K., Shimokawa, N., Szymkiewicz, I., and Dikic, I. Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors. Proc. Natl. Acad. Sci. USA, 99: 12191-12196, 2002.